شراء AstraZeneca xStock (AZNX) في Japan

AstraZeneca xStock, identified by the ticker symbol AZNX, is a digital asset categorized as a tokenized stock or tracker certificate. This project aims to bridge traditional equity markets with the blockchain ecosystem by providing a digital representation of shares in AstraZeneca PLC, a major global biopharmaceutical company. The AZNX token is issued on multiple blockchain networks, including Ethereum as an ERC-20 token and Solana as an SPL token. Its primary function is to track the price movement of the underlying AstraZeneca stock. This allows participants in the cryptocurrency market to gain exposure to the price fluctuations of a traditional public company through a digital medium without needing a traditional brokerage account. Each AZNX token is designed to be backed on a one-to-one basis by actual shares of AstraZeneca PLC. These physical shares are typically held in custody by a regulated third-party financial institution to ensure that the digital tokens correspond to real-world assets. However, it is important to note that holding these tokens does not equate to direct ownership of the company. Unlike traditional shareholders, holders of AZNX typically do not receive voting rights or other standard shareholder privileges. One of the key features of this project is the increased accessibility it provides. By utilizing blockchain technology, the tokenized stock can be traded outside of traditional stock market hours, often allowing for twenty-four-five trading. Additionally, because AZNX exists as a standard token on decentralized networks, it can be integrated with various decentralized finance protocols. This allows users to use the asset within the Web3 ecosystem for purposes such as collateral or inclusion in automated trading strategies. The project is often part of a broader suite of assets known as xStocks, which represent a variety of traditional securities in tokenized form. It is primarily available on specific cryptocurrency exchanges and digital asset platforms that support tokenized equities. While it offers a way to interact with traditional market value through a blockchain interface, participants are generally advised that the asset carries the risks associated with both the underlying pharmaceutical industry and the technical nature of blockchain-based products. معرفة المزيد